Biodexa’s $10 Million Offering Unveils Growth Ambitions: Key Details on Structure and Future Funding Plans
Market Chameleon (Thu, 18-Dec 9:37 AM)
Biodexa Secures Key European Approval for Phase 3 Serenta Trial—Aiming to Address a $7 Billion Market in FAP
Market Chameleon (Mon, 3-Nov 8:50 AM)
